
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Дек. 9, 2024
Язык: Английский
Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Дек. 9, 2024
Язык: Английский
Journal of Reproductive Immunology, Год журнала: 2024, Номер 166, С. 104325 - 104325
Опубликована: Сен. 6, 2024
Язык: Английский
Процитировано
0Pathogens, Год журнала: 2024, Номер 13(9), С. 811 - 811
Опубликована: Сен. 19, 2024
Introduction: Post-menopausal women living with Human Immunodeficiency Virus (WLHIV) face an increased risk of bone fractures due to the relationship between HIV-related factors and menopause. This narrative review aims summarise current knowledge about fracture among post-menopausal WLHIV in particular looking at hormonal changes, combined antiretroviral therapy (cART), lifestyle factors, psychosocial implications. We also profiled a summary significant, recent studies residing low-income countries (LIC). Methods: A thorough search literature was performed across PubMed, Medline, Scopus, Google Scholar, focussing on published 2000 2024. Inclusion criteria entailed original research, reviews, meta-analyses addressing mineral density (BMD), incidence, related WLHIV. Results: The identified 223 relevant studies. exhibit significantly lower BMD higher rates compared both HIV-negative pre-menopausal cART, particularly tenofovir disoproxil fumarate (TDF), contributes reduced BMD. Menopausal status exacerbates this through decreased oestrogen levels, leading resorption. Moreover, choices such as smoking, alcohol consumption, low physical activity are more prevalent PWHIV, which further elevates risk. Different may make WLWHIV vulnerable stage their life, depression, isolation, stigma, housing nutritional issues. Women LICs variety challenges accessing HIV care. There gaps research prevalence osteoporosis loss LICs. Conclusion: effects Antiretroviral (particularly TDF), exacerbate is need for careful selection hormone replacement (HRT), emerging treatments Abaloparatide. holistic approach including changes support crucial reduce WLHIV, especially countries.
Язык: Английский
Процитировано
0Опубликована: Сен. 4, 2024
Perimenopause is the period when women experience a decline in reproductive abilities and adjust to changes estrogen production. It typically begins mid-40s can last until menopause. During this time, may symptoms such as irregular menstrual cycles, hot flashes, sleep disturbances, mood swings. Menopause confirmed after 12 consecutive months without period.Estrogen deficiency, hormone with extensive metabolic effects, decreases during menopause, leading increased risks of cardiovascular diseases, hormone-sensitive breast cancer, other chronic illnesses. These be mitigated through lifestyle changes.Common perimenopause menopause include night sweats, headaches, joint pain, which vary intensity are influenced by lifestyle.In conclusion, delay development associated alleviate symptoms, improve daily life.
Язык: Английский
Процитировано
0Nutrients, Год журнала: 2024, Номер 16(23), С. 4219 - 4219
Опубликована: Дек. 6, 2024
Correction of decreased diversity the gut microbiome, which is characteristic menopause, by supplementation with a synbiotic may attenuate or prevent dysbiosis processes and preserve bone mass. We describe rationale design OsteoPreP trial aimed at evaluating effects 12 months on metabolic health in postmenopausal Caucasian women.
Язык: Английский
Процитировано
0Research Square (Research Square), Год журнала: 2024, Номер unknown
Опубликована: Дек. 9, 2024
Язык: Английский
Процитировано
0